SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-004279
Filing Date
2020-12-14
Accepted
2020-12-14 11:15:06
Documents
9
Period of Report
2020-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT xenetic_8k.htm 8-K 30090
2 OPINION xenetic_ex0501.htm EX-5.1 12774
3 SECURITIES PURCHASE AGREEMENT xenetic_ex1001.htm EX-10.2 208215
4 ENGAGEMENT LETTER xenetic_ex1002.htm EX-10.1 53946
5 PRESS RELEASE xenetic_ex9901.htm EX-99.1 14406
6 PRESS RELEASE xenetic_ex9902.htm EX-99.2 14468
7 GRAPHIC image_001.jpg GRAPHIC 7343
8 GRAPHIC image_002.jpg GRAPHIC 3392
9 GRAPHIC image_003.jpg GRAPHIC 3392
  Complete submission text file 0001683168-20-004279.txt   355114
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 201385442
SIC: 2834 Pharmaceutical Preparations